Unknown

Dataset Information

0

Risk Factors for Major Hemorrhage Among Patients Receiving Dabigatran Across the Spectrum of CKD Not Requiring Dialysis Therapy.

ABSTRACT:

SUBMITTER: Davis BH 

PROVIDER: S-EPMC8546791 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The Risk of Major Hemorrhage with CKD.
| S-EPMC5004646 | biostudies-literature
Unknown A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study.
| S-EPMC8258589 | biostudies-literature
Unknown Adult height in patients with advanced CKD requiring renal replacement therapy during childhood.
| S-EPMC3878688 | biostudies-literature
Unknown Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care.
| S-EPMC8000881 | biostudies-literature
Unknown Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
| S-EPMC4898697 | biostudies-literature
Unknown Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran.
| S-EPMC6852568 | biostudies-literature
Unknown Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non-dialysis CKD: An observational study.
| S-EPMC8204094 | biostudies-literature
Unknown Temporal changes in incidence of dialysis-requiring AKI.
| S-EPMC3537221 | biostudies-literature
Unknown Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran.
| S-EPMC5121568 | biostudies-literature
Unknown COVID-19 Risk Factors and Mortality Outcomes Among Medicare Patients Receiving Long-term Dialysis.
| S-EPMC8600389 | biostudies-literature